These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 33729)

  • 1. Monoacylcadaverines in schizophrenia.
    Dolezalova H; Stepita-Klauco M; van der Velde C; Cassone V
    Biol Psychiatry; 1979 Feb; 14(1):27-35. PubMed ID: 33729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoacylcadaverines in the blood of schizophrenic patients.
    Dolezalova H; Klauco MS
    J Chromatogr; 1978 Jul; 146(1):67-76. PubMed ID: 670359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.
    Yovel G; Sirota P; Mazeh D; Shakhar G; Rosenne E; Ben-Eliyahu S
    Brain Behav Immun; 2000 Sep; 14(3):153-69. PubMed ID: 10970677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
    Petronijević ND; Radonjić NV; Ivković MD; Marinković D; Piperski VD; Duricić BM; Paunović VR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1921-6. PubMed ID: 18824063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract]   [Full Text] [Related]  

  • 8. [B-lymphocytes of the blood in schizophrenia: effect of psychotropic therapy].
    Potapova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1378-81. PubMed ID: 2866649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
    Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
    Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S; Barone R; Molinaro G; Leone NB
    Minerva Psichiatr; 1987; 28(1):31-4. PubMed ID: 2888003
    [No Abstract]   [Full Text] [Related]  

  • 11. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.
    Olincy A; Young DA; Freedman R
    Biol Psychiatry; 1997 Jul; 42(1):1-5. PubMed ID: 9193735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].
    Jarema M; Choma M; Kozłowski P; Poniatowska R; Krawczyk R
    Psychiatr Pol; 1997; 31(5):547-57. PubMed ID: 9547181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood glucose in chronic schizophrenic patients treated with antipsychotics].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Mar; 34(2):76-80. PubMed ID: 17160751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.